Stay updated through our LinkedIn!
Press releases
Revolutionary Landmark Study on Repeated Low-Level Red-Light (RLRL) Therapy and Orthokeratology Published!
The findings promise to revolutionize how we approach myopia treatment , offering new hope to patients with myopia worldwide. Kudos to the dedicated research team for their hard work Read more here >
A response to ‘Red light instruments for myopia exceed safety limits’
John Battersby First published: 01 March 2024 To the Editor, Paul Cooke, the CEO of Eyerising International, an Australian company that is the legal manufacturer of a Repeated Low-Level Red-Light device, would appreciate an opportunity[...]
Eyerising International Refute Inaccurate Claims in OPO Article
Eyerising International list multiple errors and inaccuracies in the article: • The authors incorrectly alleged the Eyerising device did not meet safety standards it claimed • The authors tested devices to the wrong ANSI standards[...]
Daring Descents For A Cause: Eyerising International Sponsors Young Adventurers At The Brighton i360 Experience
An unforgettable adventure unfolded as young thrill-seekers, Ella (17) and Tegan Hemming (15), took on the iconic i360 experience in Brighton. This adrenaline-pumping descent from a towering structure was not only a test of courage[...]
